Ascendis Pharma Accounts Receivable (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

135.13 -2.32 (-1.69%) USD | NASDAQ | May 31, 16:00

135.13 0.00 (0.00%) Pre-Market: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	44.38M
December 31, 2023	39.66M
September 30, 2023	28.36M
June 30, 2023	21.97M
March 31, 2023	17.58M
December 31, 2022	12.77M
September 30, 2022	6.541M
June 30, 2022	4.564M
March 31, 2022	6.482M
December 31, 2021	2.491M
September 30, 2021	0.6182M
June 30, 2021	0.4689M
March 31, 2021	0.0703M
December 31, 2020	0.476M
September 30, 2020	3.196M
June 30, 2020
March 31, 2020
December 31, 2019	0.9006M
September 30, 2019	0.00
June 30, 2019	0.00

Date	Value
March 31, 2019	0.0045M
December 31, 2018	0.0069M
September 30, 2018	0.0244M
June 30, 2018	0.0197M
March 31, 2018	0.0419M
December 31, 2017	0.2255M
September 30, 2017	0.5231M
June 30, 2017	0.5148M
March 31, 2017	0.4039M
December 31, 2016	0.3034M
September 30, 2016	0.4701M
June 30, 2016	0.436M
March 31, 2016	1.006M
December 31, 2015	1.163M
September 30, 2015	0.8293M
June 30, 2015	1.512M
March 31, 2015	0.9205M
December 31, 2014	1.571M
September 30, 2014	1.482M
December 31, 2013	2.354M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

Minimum

Jun 2019

44.38M

Maximum

Mar 2024

10.58M

Average

3.880M

Median

Accounts Receivable (Quarterly) Benchmarks